{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:25:34Z","timestamp":1787171134678,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019832","name":"Galapagos NV","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019832","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009318","name":"Helmholtz Association of German Research Centres","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jid.2026.07.033","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:20:55Z","timestamp":1787095255000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition of Salt-Inducible Kinases 2 and 3 reduces inflammatory signature in Psoriasis"],"prefix":"10.1016","author":[{"given":"Anna Caroline","family":"Pilz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Briem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel","family":"Colli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Hillig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lavazais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Menden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilo","family":"Biedermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Lauffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Eyerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"De Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manja","family":"Jargosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaad.2022.07.002","article-title":"Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial","volume":"88","author":"Armstrong","year":"2023","journal-title":"J. Am. Acad. Dermatol"},{"issue":"8","key":"10.1016\/j.jid.2026.07.033_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis Prevalence in Adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jid.2026.07.033_bib3","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI1476","article-title":"IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach","volume":"101","author":"Asadullah","year":"1998","journal-title":"J. Clin. Invest"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib4","article-title":"Identification of highly selective SIK1\/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation","volume":"121","author":"Babbe","year":"2024","journal-title":"Proc. Natl. Acad. Sci. Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc. Ser. B Methodol"},{"issue":"5","key":"10.1016\/j.jid.2026.07.033_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib7","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jid.2018.07.025","article-title":"A Critical Role of the IL-1\u03b2-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis","volume":"139","author":"Cai","year":"2019","journal-title":"J. Invest. Dermatol"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib8","first-page":"563","article-title":"Inflammatory cytokine production by human neutrophils involves C\/EBP transcription factors","volume":"182","author":"Cloutier","year":"1950","journal-title":"J. Immunol. Baltim. Md"},{"issue":"3","key":"10.1016\/j.jid.2026.07.033_bib9","article-title":"Selective SIK2\/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes","volume":"11","author":"De Vos","year":"2026","journal-title":"JCI Insight. American Society for Clinical Investigation"},{"issue":"9","key":"10.1016\/j.jid.2026.07.033_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049822","article-title":"IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)","volume":"11","author":"Eyerich","year":"2021","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.jid.2026.07.033_bib11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/s41592-023-01943-7","article-title":"Unsupervised removal of systematic background noise from droplet-based single-cell experiments using CellBender","volume":"20","author":"Fleming","year":"2023","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jid.2026.07.033_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2024.103167","article-title":"IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis","volume":"143","author":"Furuya","year":"2024","journal-title":"J. Autoimmun"},{"issue":"4","key":"10.1016\/j.jid.2026.07.033_bib13","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.jaci.2017.07.045","article-title":"Toll-like receptor 7\/8 agonists stimulate plasmacytoid dendritic cells to initiate TH17-deviated acute contact dermatitis in human subjects","volume":"141","author":"Garzorz-Stark","year":"2018","journal-title":"J. Allergy Clin. Immunol"},{"issue":"4","key":"10.1016\/j.jid.2026.07.033_bib14","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/gene.2008.20","article-title":"Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells","volume":"9","author":"Grant","year":"2008","journal-title":"Genes Immun"},{"issue":"14","key":"10.1016\/j.jid.2026.07.033_bib15","first-page":"6482","article-title":"Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory Diseases","volume":"62","author":"Haile","year":"2019","journal-title":"J. Med. Chem. American Chemical Society"},{"issue":"2","key":"10.1016\/j.jid.2026.07.033_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41419-022-04633-y","article-title":"Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/exd.13403","article-title":"Imiquimod-applied Interleukin-10 deficient mice better reflects severe and persistent psoriasis with systemic inflammatory state","volume":"27","author":"Jin","year":"2018","journal-title":"Exp. Dermatol"},{"issue":"3","key":"10.1016\/j.jid.2026.07.033_bib18","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jdermsci.2020.09.014","article-title":"Phosphodiesterase-4 inhibitors reduce the expression of proinflammatory mediators by human epidermal keratinocytes independent of intracellular cAMP elevation","volume":"100","author":"Kataoka","year":"2020","journal-title":"J. Dermatol. Sci"},{"issue":"10","key":"10.1016\/j.jid.2026.07.033_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archderm.138.10.1341","article-title":"Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10","volume":"138","author":"Kimball","year":"2002","journal-title":"Arch. Dermatol"},{"key":"10.1016\/j.jid.2026.07.033_bib20","unstructured":"Kolde R. pheatmap: Pretty Heatmaps. R package version 1.0.12, https:\/\/github.com\/raivokolde\/pheatmap. 2018."},{"key":"10.1016\/j.jid.2026.07.033_bib21","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2016","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.jid.2026.07.033_bib22","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jid.2018.02.034","article-title":"Type I Immune Response Induces Keratinocyte Necroptosis and Is Associated with Interface Dermatitis","volume":"138","author":"Lauffer","year":"2018","journal-title":"J. Invest. Dermatol"},{"issue":"683","key":"10.1016\/j.jid.2026.07.033_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj3289","article-title":"IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases","volume":"15","author":"Lavazais","year":"2023","journal-title":"Sci. Transl. Med"},{"issue":"12","key":"10.1016\/j.jid.2026.07.033_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0. Bioinforma. Oxf. Engl","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"issue":"12","key":"10.1016\/j.jid.2026.07.033_bib25","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41592-018-0229-2","article-title":"Deep generative modeling for single-cell transcriptomics","volume":"15","author":"Lopez","year":"2018","journal-title":"Nat. Methods"},{"issue":"12","key":"10.1016\/j.jid.2026.07.033_bib26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/j.jid.2026.07.033_bib27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.cell.2015.05.002","article-title":"Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets","volume":"161","author":"Macosko","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jid.2026.07.033_bib28","article-title":"UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction","author":"McInnes","year":"2020","journal-title":"arXiv"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2014.01.068","article-title":"Matrix metalloproteinases and their role in psoriasis","volume":"540","author":"Mezentsev","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.jid.2026.07.033_bib30","first-page":"21","article-title":"Phosphodiesterase-4 Inhibition in Psoriasis","volume":"11","author":"Milakovic","year":"2021","journal-title":"Psoriasis Auckl. NZ"},{"issue":"5","key":"10.1016\/j.jid.2026.07.033_bib31","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaad.2019.01.066","article-title":"Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study","volume":"80","author":"Mrowietz","year":"2019","journal-title":"J. Am. Acad. Dermatol"},{"issue":"2","key":"10.1016\/j.jid.2026.07.033_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/pdia.2014.40920","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"31","author":"Nedoszytko","year":"2014","journal-title":"Postepy Dermatol. Alergol"},{"key":"10.1016\/j.jid.2026.07.033_bib33","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.jid.2026.07.033_bib34","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1021\/acs.jmedchem.3c02246","article-title":"Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2\/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases","volume":"67","author":"Peixoto","year":"2024","journal-title":"J. Med. Chem"},{"issue":"6527","key":"10.1016\/j.jid.2026.07.033_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6500","article-title":"Developmental cell programs are co-opted in inflammatory skin disease","volume":"371","author":"Reynolds","year":"2021","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jid.2026.07.033_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00125-016-4141-y","article-title":"Salt-inducible kinase 2 and -3 are downregulated in adipose tissue from obese or insulin-resistant individuals: implications for insulin signalling and glucose uptake in human adipocytes","volume":"60","author":"S\u00e4ll","year":"2017","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.jid.2026.07.033_bib37","first-page":"CD011535","article-title":"Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","volume":"5","author":"Sbidian","year":"2022","journal-title":"Cochrane Database Syst. Rev"},{"issue":"9","key":"10.1016\/j.jid.2026.07.033_bib38","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cellsig.2014.05.014","article-title":"Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity","volume":"26","author":"Schafer","year":"2014","journal-title":"Cell. Signal"},{"issue":"4","key":"10.1016\/j.jid.2026.07.033_bib39","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1476-5381.2009.00559.x","article-title":"Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis","volume":"159","author":"Schafer","year":"2010","journal-title":"Br. J. Pharmacol"},{"issue":"5","key":"10.1016\/j.jid.2026.07.033_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1759720X10381432","article-title":"Apremilast: a novel PDE4 inhibitor in the treatment of autoimmune and inflammatory diseases","volume":"2","author":"Schett","year":"2010","journal-title":"Ther. Adv. Musculoskelet. Dis"},{"key":"10.1016\/j.jid.2026.07.033_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2024.1426244","article-title":"Understanding the roles of salt-inducible kinases in cardiometabolic disease","volume":"15","author":"Shi","year":"2024","journal-title":"Front. Physiol"},{"issue":"2","key":"10.1016\/j.jid.2026.07.033_bib42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The Immunology of Psoriasis-Current Concepts in Pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin. Rev. Allergy Immunol"},{"key":"10.1016\/j.jid.2026.07.033_bib43","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2017.01.005","article-title":"CCAAT\/Enhancer-binding protein \u03b2 promotes pathogenesis of EAE","volume":"92","author":"Simpson-Abelson","year":"2017","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib44","article-title":"The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis","volume":"2019","author":"Sun","year":"2019","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.jid.2026.07.033_bib45","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/978-981-15-1580-4_3","article-title":"CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond","volume":"1204","author":"Sung","year":"2020","journal-title":"Adv. Exp. Med. Biol"},{"issue":"10","key":"10.1016\/j.jid.2026.07.033_bib46","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jamadermatol.2019.1394","article-title":"Efficacy and Safety of Guselkumab in Japanese Patients With Palmoplantar Pustulosis: A Phase 3 Randomized Clinical Trial","volume":"155","author":"Terui","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.jid.2026.07.033_bib47","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s40257-023-00788-2","article-title":"Efficacy and Safety of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: Results from a Phase 2, Randomized, Placebo-Controlled Study","volume":"24","author":"Terui","year":"2023","journal-title":"Am. J. Clin. Dermatol"},{"key":"10.1016\/j.jid.2026.07.033_bib48","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.206","article-title":"Direct Comparison of Real-world Effectiveness of Biologics for Psoriasis using Absolute and Relative Psoriasis Area and Severity Index Scores in a Prospective Multicentre Cohort","volume":"102","author":"Van Muijen","year":"2022","journal-title":"Acta Derm. Venereol"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib49","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13059-017-1382-0","article-title":"SCANPY: large-scale single-cell gene expression data analysis","volume":"19","author":"Wolf","year":"2018","journal-title":"Genome Biol"},{"issue":"4","key":"10.1016\/j.jid.2026.07.033_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell Syst"},{"issue":"91","key":"10.1016\/j.jid.2026.07.033_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi2848","article-title":"A single-cell atlas of IL-23 inhibition in cutaneous psoriasis distinguishes clinical response","volume":"9","author":"Wu","year":"2024","journal-title":"Sci. Immunol"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib52","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20209620","article-title":"Probabilistic harmonization and annotation of single\u2010cell transcriptomics data with deep generative models","volume":"17","author":"Xu","year":"2021","journal-title":"Mol. Syst. Biol"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/s12967-024-05539-3","article-title":"Dual role of CD177 + neutrophils in inflammatory bowel disease: a review","volume":"22","author":"Zheng","year":"2024","journal-title":"J. Transl. Med"},{"issue":"1","key":"10.1016\/j.jid.2026.07.033_bib54","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41420-023-01524-9","article-title":"The role of CXCL family members in different diseases","volume":"9","author":"Zhou","year":"2023","journal-title":"Cell Death Discov"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26027405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26027405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:49:57Z","timestamp":1787168997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26027405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"alternative-id":["S0022202X26027405"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.07.033","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Salt-Inducible Kinases 2 and 3 reduces inflammatory signature in Psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.07.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}